Nifty
:
25114.00
Sensex
:
81904.70
108.50 (0.43%)
355.97 (0.44%)
Nifty
Sensex
:
:
25114.00
81904.70
108.50 (0.43%)
355.97 (0.44%)

Kwality Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :
68/99

BSE: 539997 | NSE: Not Listed

NSE BSE
988.05
12-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  969.4
  •  992.95
  •  961.1
  •  969.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  8236
  •  8070920
  •  992.95
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,025.22
  • 23.61
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,122.91
  • N/A
  • 3.73

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.83%
  • 1.92%
  • 33.33%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 9.92%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.44
  • 7.16
  • 13.82

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 31.96
  • 22.74
  • 5.77

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 38.36
  • 21.33
  • 27.17

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.91
  • 25.27
  • 25.41

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.85
  • 4.38
  • 2.64

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.59
  • 10.49
  • 8.60

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
111.48
80.08
39.21%
115.68
91.98
25.77%
84.41
78.09
8.09%
90.03
69.65
29.26%
Expenses
87.30
62.74
39.15%
89.79
71.35
25.84%
66.91
61.41
8.96%
70.37
54.42
29.31%
EBITDA
24.18
17.34
39.45%
25.89
20.63
25.50%
17.50
16.68
4.92%
19.66
15.23
29.09%
EBIDTM
21.69%
21.66%
22.38%
22.43%
20.73%
21.36%
21.84%
21.87%
Other Income
0.38
0.28
35.71%
0.77
0.58
32.76%
0.66
0.62
6.45%
0.22
0.23
-4.35%
Interest
2.76
2.48
11.29%
2.49
3.06
-18.63%
2.20
2.73
-19.41%
2.71
2.41
12.45%
Depreciation
4.76
4.03
18.11%
5.09
5.07
0.39%
4.56
4.82
-5.39%
4.62
4.88
-5.33%
PBT
17.03
11.12
53.15%
19.07
5.99
218.36%
11.39
9.75
16.82%
12.55
8.17
53.61%
Tax
5.11
2.77
84.48%
4.59
1.75
162.29%
2.87
2.07
38.65%
4.10
1.95
110.26%
PAT
11.92
8.35
42.75%
14.48
4.24
241.51%
8.52
7.68
10.94%
8.46
6.22
36.01%
PATM
10.69%
10.42%
12.52%
4.61%
10.10%
9.83%
9.39%
8.92%
EPS
11.49
8.05
42.73%
13.96
4.21
231.59%
8.22
7.41
10.93%
8.16
6.01
35.77%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
401.60
370.20
307.17
251.03
456.19
262.01
139.30
166.29
137.49
98.32
74.17
Net Sales Growth
25.58%
20.52%
22.36%
-44.97%
74.11%
88.09%
-16.23%
20.95%
39.84%
32.56%
 
Cost Of Goods Sold
201.51
116.19
89.63
69.44
141.83
165.59
87.08
119.44
101.59
71.29
56.77
Gross Profit
200.09
254.00
217.55
181.59
314.36
96.42
52.22
46.85
35.91
27.03
17.40
GP Margin
49.82%
68.61%
70.82%
72.34%
68.91%
36.80%
37.49%
28.17%
26.12%
27.49%
23.46%
Total Expenditure
314.37
289.81
240.86
190.30
284.52
233.15
125.08
150.58
125.81
89.41
69.15
Power & Fuel Cost
-
23.37
17.23
12.98
11.07
6.13
4.20
3.71
2.71
2.81
2.31
% Of Sales
-
6.31%
5.61%
5.17%
2.43%
2.34%
3.02%
2.23%
1.97%
2.86%
3.11%
Employee Cost
-
41.26
30.46
28.16
18.80
14.70
10.92
7.74
4.89
3.60
2.16
% Of Sales
-
11.15%
9.92%
11.22%
4.12%
5.61%
7.84%
4.65%
3.56%
3.66%
2.91%
Manufacturing Exp.
-
71.16
75.33
50.12
68.37
6.87
3.54
2.87
5.16
2.64
1.41
% Of Sales
-
19.22%
24.52%
19.97%
14.99%
2.62%
2.54%
1.73%
3.75%
2.69%
1.90%
General & Admin Exp.
-
18.07
17.66
16.11
9.10
12.80
8.46
5.83
3.18
2.58
2.77
% Of Sales
-
4.88%
5.75%
6.42%
1.99%
4.89%
6.07%
3.51%
2.31%
2.62%
3.73%
Selling & Distn. Exp.
-
18.22
8.71
12.66
35.13
26.09
10.60
10.79
8.06
5.04
3.29
% Of Sales
-
4.92%
2.84%
5.04%
7.70%
9.96%
7.61%
6.49%
5.86%
5.13%
4.44%
Miscellaneous Exp.
-
1.52
1.83
0.83
0.23
0.97
0.28
0.19
0.23
1.46
3.29
% Of Sales
-
0.41%
0.60%
0.33%
0.05%
0.37%
0.20%
0.11%
0.17%
1.48%
0.59%
EBITDA
87.23
80.39
66.31
60.73
171.67
28.86
14.22
15.71
11.68
8.91
5.02
EBITDA Margin
21.72%
21.72%
21.59%
24.19%
37.63%
11.01%
10.21%
9.45%
8.50%
9.06%
6.77%
Other Income
2.03
1.92
1.83
2.94
3.51
1.59
3.66
0.61
0.80
1.21
0.36
Interest
10.16
9.88
10.39
6.61
2.92
2.68
2.52
2.29
2.21
1.95
1.22
Depreciation
19.03
18.29
19.56
14.96
10.69
6.49
4.43
3.12
2.98
2.51
1.69
PBT
60.04
54.14
38.20
42.10
161.57
21.27
10.92
10.91
7.30
5.65
2.48
Tax
16.67
14.34
7.48
6.29
41.63
6.38
2.71
3.35
2.87
2.37
1.19
Tax Rate
27.76%
26.49%
24.05%
24.60%
25.77%
30.00%
24.82%
30.71%
39.32%
41.95%
47.98%
PAT
43.38
39.84
23.80
19.37
119.99
15.15
8.32
7.56
4.54
3.37
1.55
PAT before Minority Interest
43.43
39.80
23.62
19.28
119.94
14.89
8.21
7.56
4.42
3.28
1.28
Minority Interest
0.05
0.04
0.18
0.09
0.05
0.26
0.11
0.00
0.12
0.09
0.27
PAT Margin
10.80%
10.76%
7.75%
7.72%
26.30%
5.78%
5.97%
4.55%
3.30%
3.43%
2.09%
PAT Growth
63.76%
67.39%
22.87%
-83.86%
692.01%
82.09%
10.05%
66.52%
34.72%
117.42%
 
EPS
41.71
38.31
22.88
18.63
115.38
14.57
8.00
7.27
4.37
3.24
1.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
264.05
224.21
200.52
181.14
61.15
46.01
37.30
29.75
25.58
21.34
Share Capital
10.38
10.38
10.38
10.38
10.38
10.38
10.38
10.38
5.19
5.01
Total Reserves
253.67
213.84
190.14
170.77
50.78
35.63
26.92
19.37
20.40
16.75
Non-Current Liabilities
13.76
19.75
28.62
21.32
28.08
19.78
8.23
5.47
4.24
3.32
Secured Loans
15.12
19.56
27.19
19.59
16.26
8.18
7.01
3.11
2.63
2.35
Unsecured Loans
0.00
0.00
0.12
0.70
2.00
2.00
0.58
1.59
0.67
0.35
Long Term Provisions
0.25
0.22
0.90
0.75
0.68
0.62
0.52
0.55
0.54
0.17
Current Liabilities
169.50
151.85
125.95
139.49
78.29
67.75
60.83
61.98
41.60
26.54
Trade Payables
55.79
44.32
35.19
34.51
26.21
22.97
17.07
22.14
12.74
9.67
Other Current Liabilities
24.28
34.91
33.31
40.97
29.82
20.55
21.73
15.91
11.46
5.94
Short Term Borrowings
83.33
66.02
50.96
23.00
16.45
21.24
18.73
21.33
15.09
9.65
Short Term Provisions
6.10
6.60
6.48
41.00
5.80
3.00
3.30
2.60
2.30
1.28
Total Liabilities
445.66
394.18
353.64
340.60
166.22
132.50
105.38
96.21
70.92
51.20
Net Block
145.69
139.05
120.50
91.73
56.53
42.69
29.08
20.38
17.01
12.72
Gross Block
231.57
206.64
170.15
128.13
82.22
62.60
47.64
35.82
29.58
22.78
Accumulated Depreciation
85.87
67.58
49.65
36.39
25.69
19.91
18.56
15.44
12.56
10.06
Non Current Assets
161.88
151.49
146.43
112.77
60.33
43.46
29.99
21.14
17.75
12.88
Capital Work in Progress
0.00
0.00
14.29
12.15
2.89
0.00
0.00
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.73
0.65
0.79
0.63
0.62
0.03
Long Term Loans & Adv.
16.19
12.44
10.71
8.11
0.17
0.12
0.12
0.12
0.12
0.12
Other Non Current Assets
0.00
0.00
0.93
0.78
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
283.78
242.69
207.20
227.82
105.90
89.03
75.35
75.00
53.07
38.19
Current Investments
0.00
0.00
0.00
0.00
4.44
3.34
4.04
4.71
3.03
1.91
Inventories
83.47
78.39
86.31
53.36
17.36
22.42
11.25
15.03
13.85
10.35
Sundry Debtors
154.31
114.39
71.69
69.13
35.71
30.33
38.43
37.03
22.61
18.03
Cash & Bank
14.76
5.94
7.36
12.95
5.81
1.54
1.40
1.61
2.99
1.35
Other Current Assets
31.25
7.03
0.00
0.00
42.58
31.41
20.24
16.61
10.58
6.56
Short Term Loans & Adv.
31.25
36.94
41.83
92.38
42.49
31.29
20.18
16.49
10.53
6.50
Net Current Assets
114.27
90.84
81.25
88.33
27.61
21.28
14.52
13.02
11.47
11.65
Total Assets
445.66
394.18
353.63
340.59
166.23
132.49
105.37
96.21
70.92
51.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
52.72
42.98
41.38
60.60
26.71
6.16
13.58
-0.57
4.30
-2.85
PBT
54.14
31.10
25.57
161.57
21.27
10.92
10.91
7.30
5.65
2.48
Adjustment
28.00
36.62
20.95
13.56
9.09
7.09
5.22
4.36
4.69
3.25
Changes in Working Capital
-13.63
-23.44
1.01
-73.18
2.72
-9.13
0.89
-9.17
-3.62
-7.31
Cash after chg. in Working capital
68.51
44.28
47.54
101.95
33.09
8.87
17.02
2.49
6.72
-1.58
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-15.79
-1.30
-6.16
-41.35
-6.38
-2.71
-3.44
-3.06
-2.42
-1.26
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-28.52
-26.40
-48.44
-62.93
-23.20
-17.80
-11.78
-6.20
-7.26
-2.47
Net Fixed Assets
-24.54
-22.20
-44.16
-55.17
-22.50
-14.92
-11.81
-6.25
-6.79
Net Investments
0.00
0.00
0.00
5.17
-1.18
0.92
0.08
-1.87
-1.99
Others
-3.98
-4.20
-4.28
-12.93
0.48
-3.80
-0.05
1.92
1.52
Cash from Financing Activity
-14.44
-17.40
0.99
5.66
0.77
11.77
-2.00
5.39
4.60
5.63
Net Cash Inflow / Outflow
9.76
-0.81
-6.07
3.33
4.27
0.14
-0.21
-1.38
1.65
0.31
Opening Cash & Equivalents
2.26
3.07
9.13
5.81
1.54
1.40
1.61
2.99
1.35
1.03
Closing Cash & Equivalent
12.02
2.26
3.07
9.13
5.81
1.54
1.40
1.61
2.99
1.35

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
253.70
215.31
192.48
173.81
58.16
43.57
35.14
27.83
23.79
20.78
ROA
9.48%
6.32%
5.55%
47.33%
9.97%
6.90%
7.50%
5.29%
5.37%
2.90%
ROE
16.36%
11.16%
10.15%
99.66%
28.21%
20.10%
23.13%
16.51%
14.41%
6.54%
ROCE
18.36%
13.57%
12.27%
95.32%
26.36%
18.49%
21.91%
19.19%
19.74%
12.45%
Fixed Asset Turnover
1.69
1.63
1.68
4.34
3.62
2.53
3.98
4.20
3.76
3.23
Receivable days
132.46
110.56
102.38
41.94
46.00
90.08
82.82
79.17
75.44
66.62
Inventory Days
79.79
97.85
101.54
28.29
27.71
44.10
28.84
38.34
44.92
41.35
Payable days
157.23
161.90
183.20
78.14
54.20
56.97
49.86
49.48
45.68
36.66
Cash Conversion Cycle
55.02
46.51
20.73
-7.91
19.51
77.22
61.80
68.03
74.67
71.31
Total Debt/Equity
0.43
0.44
0.45
0.35
0.68
0.77
0.79
0.92
0.77
0.62
Interest Cover
6.48
3.99
4.87
56.38
8.93
5.32
5.76
4.31
3.89
3.02

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Kwality Pharmaceuticals gets registration for Bleomycin in Mexico
    18th Aug 2025, 14:10 PM

    This approval further strengthens its expansion into highly regulated markets, reinforcing its commitment to delivering quality oncology products globally

    Read More
  • Kwality Pharma - Quarterly Results
    11th Aug 2025, 14:22 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.